Mirion Technologies (NYSE:MIR) Issues Earnings Results, Beats Expectations By $0.02 EPS

Mirion Technologies (NYSE:MIR) announced its quarterly earnings data on Tuesday. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.02, Zacks reports. Mirion Technologies had a positive return on equity of 4.33% and a negative net margin of 7.84%. Mirion Technologies updated its FY 2025 guidance to 0.450-0.500 EPS.

Mirion Technologies Stock Performance

NYSE:MIR opened at $16.44 on Thursday. Mirion Technologies has a fifty-two week low of $9.11 and a fifty-two week high of $18.81. The company has a current ratio of 2.16, a quick ratio of 1.55 and a debt-to-equity ratio of 0.43. The business’s 50-day simple moving average is $17.00 and its 200-day simple moving average is $14.07.

Analysts Set New Price Targets

MIR has been the subject of a number of recent research reports. Citigroup boosted their price target on shares of Mirion Technologies from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, December 4th. Robert W. Baird initiated coverage on shares of Mirion Technologies in a research report on Thursday, December 19th. They set an “outperform” rating and a $22.00 target price for the company. The Goldman Sachs Group lifted their price objective on Mirion Technologies from $16.00 to $21.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Finally, Baird R W raised Mirion Technologies to a “strong-buy” rating in a research note on Thursday, December 19th. Three investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, Mirion Technologies presently has a consensus rating of “Buy” and a consensus target price of $19.25.

Mirion Technologies Company Profile

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.